Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I

通过力和域间 I 调节血管性血友病因子 - 血小板结合

基本信息

  • 批准号:
    8024519
  • 负责人:
  • 金额:
    $ 44.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-12-01 至 2015-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Arterial thrombosis occurs in conditions of high fluid flow and is mediated by the binding of platelets via their receptor Glycoprotein Ib (GPIb) to the plasma protein called von Willebrand Factor (VWF) via the A1 domain. This process is normally down-regulated to prevent spontaneous adhesion and thrombosis, but is activated by high shear stress. The proposed work will test the hypothesis that binding of GPIb to A1 is down-regulated by the neighboring domains or flanking regions within VWF, so that VWF displays interdomain auto-inhibition. It will also test the hypothesis that mechanical force associated with high shear stress activates platelet binding by pulling these regulatory regions away from the A1 domain to relieve the auto- inhibition. The final hypothesis to be tested is that conditions that increase the spontaneous binding of platelets to VWF, including type 2B von Willebrand disease, do so by damaging the normal interdomain auto-inhibition. Regulatory domains and elements within VWF will be identified by cloning different regions of VWF and determining the adhesive behavior of both soluble and surface-immoblized molecules. The effect of mechanical force and shear stress on this regulation will be determined using an atomic force microscope and microfluidics after immobilizing the molecules in an oriented fashion. PUBLIC HEALTH RELEVANCE: Thrombosis prevents bleeding at the site of damaged blood vessels but can also lead to heart attacks or strokes, the leading causes of death in cardiovascular disease. Current treatments for cardiovascular disease often cause excessive bleeding, while treatments for bleeding disorders can cause thrombotic disorders. To develop new therapies without these fundamental trade- offs, we need to better understand how the thrombotic process is regulated in the body.
描述(由申请人提供):动脉血栓形成发生在高流量条件下,由血小板通过其受体糖蛋白Ib(GPIb)与血浆蛋白(称为血管性血友病因子(VWF))通过A1结构域结合介导。该过程通常被下调以防止自发性粘连和血栓形成,但被高剪切应力激活。这项工作将验证GPIb与A1的结合受到VWF内邻近结构域或侧翼区域的下调,因此VWF显示结构域间自抑制的假设。它还将测试与高剪切应力相关的机械力通过将这些调节区域从A1结构域拉离以缓解自抑制来激活血小板结合的假设。最后要检验的假设是,增加血小板与VWF自发结合的条件,包括2B型血管性血友病,通过破坏正常的结构域间自身抑制来实现。通过克隆VWF的不同区域并确定可溶性和表面固定化分子的粘附行为,将鉴定VWF内的调节结构域和元件。在以定向方式固定分子后,将使用原子力显微镜和微流体来确定机械力和剪切应力对该调节的影响。 公共卫生关系:血栓形成可以防止受损血管部位出血,但也可能导致心脏病发作或中风,这是心血管疾病死亡的主要原因。目前对心血管疾病的治疗经常导致过度出血,而对出血性疾病的治疗可能导致血栓性疾病。为了开发没有这些基本权衡的新疗法,我们需要更好地了解血栓形成过程在体内是如何调节的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy E Thomas其他文献

Wendy E Thomas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy E Thomas', 18)}}的其他基金

Computational tools for the prediction of protein orientations on material surfac
用于预测材料表面蛋白质方向的计算工具
  • 批准号:
    8445083
  • 财政年份:
    2013
  • 资助金额:
    $ 44.55万
  • 项目类别:
Development of a library of regulated Actibodies
开发受监管的 Actibodies 库
  • 批准号:
    8422966
  • 财政年份:
    2012
  • 资助金额:
    $ 44.55万
  • 项目类别:
Development of a library of regulated Actibodies
开发受监管的 Actibodies 库
  • 批准号:
    8227141
  • 财政年份:
    2012
  • 资助金额:
    $ 44.55万
  • 项目类别:
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
通过力和域间 I 调节血管性血友病因子 - 血小板结合
  • 批准号:
    8197730
  • 财政年份:
    2010
  • 资助金额:
    $ 44.55万
  • 项目类别:
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
通过力和域间 I 调节血管性血友病因子 - 血小板结合
  • 批准号:
    8771444
  • 财政年份:
    2010
  • 资助金额:
    $ 44.55万
  • 项目类别:
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
通过力和域间 I 调节血管性血友病因子 - 血小板结合
  • 批准号:
    8585085
  • 财政年份:
    2010
  • 资助金额:
    $ 44.55万
  • 项目类别:
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
通过力和域间 I 调节血管性血友病因子 - 血小板结合
  • 批准号:
    8389604
  • 财政年份:
    2010
  • 资助金额:
    $ 44.55万
  • 项目类别:
Data Access Core
数据访问核心
  • 批准号:
    8428576
  • 财政年份:
  • 资助金额:
    $ 44.55万
  • 项目类别:
Data Access Core
数据访问核心
  • 批准号:
    8659982
  • 财政年份:
  • 资助金额:
    $ 44.55万
  • 项目类别:
Data Access Core
数据访问核心
  • 批准号:
    8785032
  • 财政年份:
  • 资助金额:
    $ 44.55万
  • 项目类别:

相似海外基金

I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
  • 批准号:
    2409620
  • 财政年份:
    2024
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
  • 批准号:
    2403716
  • 财政年份:
    2024
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
  • 批准号:
    23H01718
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
  • 批准号:
    EP/W019450/1
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
  • 批准号:
    10741660
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
  • 批准号:
    2323317
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
  • 批准号:
    10062336
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
  • 批准号:
    10677869
  • 财政年份:
    2022
  • 资助金额:
    $ 44.55万
  • 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
  • 批准号:
    10746743
  • 财政年份:
    2022
  • 资助金额:
    $ 44.55万
  • 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
  • 批准号:
    10021363
  • 财政年份:
    2022
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Investment Accelerator
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了